Literature DB >> 10700549

Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons.

A Petersén1, R F Castilho, O Hansson, T Wieloch, P Brundin.   

Abstract

Disruption of intracellular calcium homeostasis is thought to play a role in neurodegenerative disorders such as Huntington's disease (HD). To study different aspects of putative pathogenic mechanisms in HD, we aimed to establish an in vitro model of calcium-induced toxicity in striatal neurons. The calcium ionophore A23187 induced a concentration- and time-dependent cell death in cultures of embryonic striatal neurons, causing both apoptosis and necrosis. Cell death was significantly reduced by the cell-permeant antioxidant manganese(III)tetrakis(4-benzoic acid) porphyrin (MnTBAP). Cyclosporin A and its analogue N-MeVal-4-cyclosporin also reduced the incidence of cell death, suggesting the participation of mitochondrial permeability transition in this process. Furthermore, addition of either of two types of caspase inhibitors, Ac-YVAD-CHO (acetyl-Tyr-Val-Ala-Asp-aldehyde) and Ac-DEVD-CHO (acetyl-Asp-Glu-Val-Asp-aldehyde), to the striatal cells blocked A23187-induced striatal cell death in a concentration-dependent manner. These results suggest that oxidative stress, opening of the mitochondrial permeability transition pore and activation of caspases are important steps in A23187-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700549     DOI: 10.1016/s0006-8993(99)02320-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

2.  Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.

Authors:  Rajat Sandhir; Aarti Yadav; Arpit Mehrotra; Aditya Sunkaria; Amandeep Singh; Sadhna Sharma
Journal:  Neuromolecular Med       Date:  2013-09-06       Impact factor: 3.843

Review 3.  Metabolism in HD: still a relevant mechanism?

Authors:  Wenzhen Duan; Mali Jiang; Jing Jin
Journal:  Mov Disord       Date:  2014-08-13       Impact factor: 10.338

4.  Role of calcium independent phospholipase A2 in maintaining mitochondrial membrane potential and preventing excessive exocytosis in PC12 cells.

Authors:  May-Thu Ma; Jin-Fei Yeo; Akhlaq A Farooqui; Wei-Yi Ong
Journal:  Neurochem Res       Date:  2010-11-30       Impact factor: 3.996

5.  Afferent regulation of oxidative stress in the chick cochlear nucleus.

Authors:  A H Nicholas; R L Hyson
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

Review 6.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Authors:  Rodrigo A Quintanilla; Gail V W Johnson
Journal:  Brain Res Bull       Date:  2009-07-19       Impact factor: 4.077

7.  Ketamine inhibits calcium elevation and hydroxyl radical and nitric oxide production in lipopolysaccharide-stimulated NR8383 alveolar macrophages.

Authors:  Xiaobao Zhang; Jiying Feng; Pin Zhu; Zhibin Zhao
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

8.  The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.

Authors:  Eun-Young Ahn; George Pan; Jae Hwan Oh; Ewan M Tytler; Jay M McDonald
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells.

Authors:  Di-Ling Chen; Peng Zhang; Li Lin; Ou Shuai; He-Ming Zhang; Song-Hao Liu; Jin-Yu Wang
Journal:  Cell Mol Neurobiol       Date:  2013-06-29       Impact factor: 5.046

Review 10.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.